Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy can reliably distinguish between alopecia areata and trichotillomania.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

An alternating inflatable head pad reduced pressure ulcers and hair loss in heart surgery patients.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

The summit aimed to speed up finding treatments for alopecia areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

AA-PRP injections effectively increase hair count and thickness for male pattern hair loss.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Omics techniques are needed to understand the scalp microbiome's role in alopecia areata for new treatments.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

A man with a birthmark on his scalp developed hair loss that improved with treatment, but the link between the birthmark and hair loss was unclear.

Both microneedling and injections are equally effective for treating alopecia areata.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.